AMAM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Ambrx Biopharma to Johnson & Johnson Jan 8, 2024 09:03AM
AMAM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Ambrx Biopharma to Johnson & Johnson Jan 8, 2024 09:03AM
Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences May 11, 2023 04:23PM